These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 25755089)

  • 1. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
    Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
    Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
    Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
    Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway.
    Li H; Huang J; Yang B; Xiang T; Yin X; Peng W; Cheng W; Wan J; Luo F; Li H; Ren G
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):180-90. PubMed ID: 23707762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis.
    Arunkumar R; Sharmila G; Elumalai P; Senthilkumar K; Banudevi S; Gunadharini DN; Benson CS; Daisy P; Arunakaran J
    Phytomedicine; 2012 Jul; 19(10):912-23. PubMed ID: 22739413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diallyl disulfide causes caspase-dependent apoptosis in human cancer cells through a Bax-triggered mitochondrial pathway.
    Nagaraj NS; Anilakumar KR; Singh OV
    J Nutr Biochem; 2010 May; 21(5):405-12. PubMed ID: 19423321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions.
    Lai KC; Hsu SC; Kuo CL; Yang JS; Ma CY; Lu HF; Tang NY; Hsia TC; Ho HC; Chung JG
    Environ Toxicol; 2013 Sep; 28(9):479-88. PubMed ID: 21695758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM
    Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
    Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
    Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
    J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.
    Nakagawa H; Tsuta K; Kiuchi K; Senzaki H; Tanaka K; Hioki K; Tsubura A
    Carcinogenesis; 2001 Jun; 22(6):891-7. PubMed ID: 11375895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into drug sensitizing effect of diallyl disulfide and diallyl trisulfide from Allium sativum L. on paclitaxel-resistant triple-negative breast cancer cells.
    Marni R; Kundrapu DB; Chakraborti A; Malla R
    J Ethnopharmacol; 2022 Oct; 296():115452. PubMed ID: 35690339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer.
    Su B; Su J; Zeng Y; Ding E; Liu F; Tan T; Xia H; Wu YH; Zeng X; Ling H; Jiang H; Ai XH; Su Q
    Oncol Rep; 2018 Jun; 39(6):2797-2806. PubMed ID: 29620286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
    Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G
    J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.
    Bauer D; Mazzio E; Soliman KF; Taka E; Oriaku E; Womble T; Darling-Reed S
    Anticancer Res; 2014 Jun; 34(6):2763-70. PubMed ID: 24922637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway.
    Yue Z; Guan X; Chao R; Huang C; Li D; Yang P; Liu S; Hasegawa T; Guo J; Li M
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31340526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.
    Siddhartha VT; Pindiprolu SKSS; Chintamaneni PK; Tummala S; Nandha Kumar S
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):387-397. PubMed ID: 28415882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
    Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
    Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways.
    Yin X; Zhang J; Li X; Liu D; Feng C; Liang R; Zhuang K; Cai C; Xue X; Jing F; Wang X; Wang J; Liu X; Ma H
    Int J Mol Sci; 2014 Jul; 15(7):12422-41. PubMed ID: 25026173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.